Korelasi Usia, International Prostate Symptom Score, Benign Prostatic Hyperplasia Impact Index, Kualitas Hidup, dan Tingkat Keparahan Pada Penderita Benign Prostatic Hyperplasia di RSUD Ciawi
Sari
ABSTRACT
Benign prostatic hyperplasia (BPH) is one of the common diseases in old male and is the common cause of lower urinary tract symptoms. The prevalence of this disease is not to be underestimated, reaching up to 80% in the age of 90 years. This disease also affects the quality of life of the patients. To find out the correlation of age, International Prostate Symptom Score (IPSS), Benign Prostatic Hyperplasia Impact Index (BII), quality of life, and severity of BPH patients. The study is done in urology clinic in Ciawi General Hospital on the period of June-July 2023. The samples are gathered with total sampling method, covering all the male patients with BPH that fulfilled the criteria. Data gathered through interview. Normality of the data is tested with Shapiro-wilk test. The correlation is tested with Pearson Correlation test or alternative of Spearman Correlation test. The study found a correlation of IPSS and BII (p-value = 0.005; r = 0.495), but no significance of age with IPSS and BII (p-value > 0.05). Strong correlation is found from quality of life with BII (p-value: < 0,001; r: 0,629), quality of life with severity based from IPSS (p-value: < 0,001; r: 0,655), and correlation between severity with IPSS and BII (p-value: 0,006; r: 0,487). Using IPSS and BII scores in clinical practice is valuable for describing a patient's severity and quality of life. We can use the results to assess the effectiveness of the treatment and measure the results.
Keywords : BII, BPH, IPSS, Quality of Life
ABSTRAK
Pembesaran jinak prostat atau benign prostatic hyperplasia (BPH) adalah salah satu penyakit paling umum pada pria lanjut usia dan penyebab paling umum dari gejala saluran kemih bagian bawah. Angka prevalensi penyakit ini juga tidak dapat dipandang sebelah mata, mencapai 80% pada usia 90 tahun. Penyakit ini juga mempengaruhi kualitas hidup penderitanya. Mengetahui korelasi usia, skor International Prostate Symptom Score (IPSS), Benign Prostatic Hyperplasia Impact Index (BII), kualitas hidup, dan tingkat keparahan pada penderita BPH. Penelitian ini dilakukan di Poli Urologi RSUD Ciawi pada periode Juni – Juli 2023. Sampel pada penelitian ini diambil dengan metode total sampling, mencakup seluruh laki-laki yang menderita BPH yang memenuhi kriteria. Data diperoleh melalui wawancara. Uji normalitas data dilakukan dengan menggunakan uji Shapiro-Wilk. Uji korelasi pada penelitian ini menggunakan uji Pearson Correlation atau uji alternatif Spearman Correlation. Didapatkan bahwa terdapat korelasi cukup yang bermakna antara IPSS dengan BII (p-value : 0,005 dan r: 0,495), tetapi tidak terdapat korelasi yang bermakna secara statistik antara usia dengan IPSS dan BII (p-value > 0,05). Terdapat korelasi kuat yang bermakna secara signifikan antara kualitas hidup dengan BII (p-value: < 0,001; r: 0,629), kualitas hidup dengan tingkat keparahan menurut IPSS (p-value: < 0,001; r: 0,655), dan korelasi cukup pada tingkat keparahan menurut IPSS dengan BII (p-value: 0,006; r: 0,487).
Penggunaan skor IPSS dan BII dalam praktik klinis membantu menggambarkan tingkat keparahan pasien, dan kualitas hidup pasien. Penelian ini membantu kita dalam mengobati dan mengevaluasi keberhasilan terapi.
Kata Kunci: BII, BPH, IPSS, Kualitas Hidup
Teks Lengkap:
Download ArtikelReferensi
Agrawal, C. S., Chalise, P. R., & Bhandari, B. B. (2008). Correlation of prostate volume with international prostate symptom score and quality of life in men with benign prostatic hyperplasia. Nepal Medical College Journal : NMCJ, 10(2), 104–107.
Angalakuditi, M., Seifert, R. F., Hayes, R. P., O’Leary, M. P., & Viktrup, L. (2010). Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies. Health and Quality of Life Outcomes, 8(1), 131. https://doi.org/10.1186/1477-7525-8-131
Choi, E. P. H., Lam, C. L. K., & Chin, W.-Y. (2014). The health-related quality of life of Chinese patients with lower urinary tract symptoms in primary care. Quality of Life Research, 23(10), 2723–2733. https://doi.org/10.1007/s11136-014-0725-5
Gratzke, C., Bachmann, A., Descazeaud, A., Drake, M. J., Madersbacher, S., Mamoulakis, C., Oelke, M., Tikkinen, K. A. O., & Gravas, S. (2015). EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. European Urology, 67(6), 1099–1109. https://doi.org/10.1016/j.eururo.2014.12.038
Kingery, L., Martin, M. L., Naegeli, A. N., Khan, S., & Viktrup, L. (2012). Content validity of the Benign Prostatic Hyperplasia Impact Index (BII); a measure of how urinary trouble and problems associated with BPH may impact the patient. International Journal of Clinical Practice, 66(9), 883–890.https://doi.org/10.1111/j.1742-1241.2012.02960.x
Lawrentschuk, N., Ptasznik, G., & Ong, S. (2021). Benign Prostate Disorders. Endotext.
Lee, C.-L., & Kuo, H.-C. (2017). Pathophysiology of benign prostate enlargement and lower urinary tract symptoms: Current concepts. Tzu Chi Medical Journal, 29(2), 79. https://doi.org/10.4103/tcmj.tcmj_20_17
Lim, K. Bin. (2017). Epidemiology of clinical benign prostatic hyperplasia. Asian Journal of Urology, 4(3), 148–151. https://doi.org/10.1016/j.ajur.2017.06.004
Lokeshwar, S. D., Harper, B. T., Webb, E., Jordan, A., Dykes, T. A., Neal Jr, D. E., Terris, M. K., & Klaassen, Z. (2019). Epidemiology and treatment modalities for the management of benign prostatic hyperplasia. Translational Andrology and Urology, 8(5), 529–539. https://doi.org/10.21037/tau.2019.10.01
Ng, M., & Baradhi, K. M. (2023). Benign Prostatic Hyperplasia. In StatPearls.
O’Leary, M. P., Wei, J. T., Roehrborn, C. G., & Miner, M. (2008). Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting. BJU International, 101(12), 1531–1535. https://doi.org/10.1111/j.1464-410X.2008.07574.x
Park, S., Ryu, J., & Lee, M. (2020). Quality of Life in Older Adults with Benign Prostatic Hyperplasia. Healthcare, 8(2), 158.https://doi.org/10.3390/healthcare8020158
Sasidharan, S., Srinivasakumar, K. P., Poddar, S., Bhaumik, A., Das, S. K., & J, H. N. (2022). Benign Prostatic Hyperplasia (BPH): A Comprehensive Analysis of the Malaise and Summarizing Possible Management Options through Phytotherapeutic Agents. Kesmas: Jurnal Kesehatan Masyarakat Nasional, 17(2). https://doi.org/10.21109/kesmas.v17i2.5887
Shao, W. H., Zheng, C. F., Ge, Y. C., Chen, X. R., Zhang, B. W., Wang, G. L., & Zhang, W. D. (2023). Age-related changes for the predictors of benign prostatic hyperplasia in Chinese men aged 40 years or older. Asian Journal of Andrology, 25(1), 132–136. https://doi.org/10.4103/aja202223
Speakman, M., Kirby, R., Doyle, S., & Ioannou, C. (2015). Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK. BJU International, 115(4), 508–519. https://doi.org/10.1111/bju.12745
Wang, J.-Y., Liao, L., Liu, M., Sumarsono, B., & Cong, M. (2018). Epidemiology of lower urinary tract symptoms in a cross-sectional, population-based study. Medicine, 97(34), e11554.https://doi.org/10.1097/MD.0000000000011554
DOI: https://doi.org/10.33024/mahesa.v3i10.11272
Refbacks
- Saat ini tidak ada refbacks.
Publisher: Universitas Malahayati Lampung
Semua artikel dapat digunakan dibawah lisensi Creative Commons Attribution-ShareAlike 4.0 International License
kostenlose besucherzähler